{"transactions":[{"id":40268,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Common Stock","published_at":"2024-06-03T20:14:23.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":7056,"price":819.38,"value":5781545.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.80 to $819.59, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25428,"source":{"system":"sec-edgar","filing":"0000059478-24-000139","document":"wk-form4_1717445655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000139/wk-form4_1717445655.xml","form_type":"4"}},{"id":46480,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2024-02-14T21:19:30.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":1308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":1308,"derivative":{"exercise_date":"2025-02-01","expiration_date":"2025-02-01","underlying":"Common Stock","underlying_shares":1308},"source":{"system":"sec-edgar","filing":"0000059478-24-000036","document":"wk-form4_1707945531.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000036/wk-form4_1707945531.xml","form_type":"4"}},{"id":46479,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Common Stock","published_at":"2024-02-14T21:19:30.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":1668,"price":737.26,"value":1229749.68,"ownership":{"direct":true},"balance_after":32484,"source":{"system":"sec-edgar","filing":"0000059478-24-000036","document":"wk-form4_1707945531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000036/wk-form4_1707945531.xml","form_type":"4"}},{"id":47658,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2024-02-02T21:24:31.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":false,"shares":1268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2024-02-01","expiration_date":"2024-02-01","underlying":"Common Stock","underlying_shares":1268},"source":{"system":"sec-edgar","filing":"0000059478-24-000017","document":"wk-form4_1706909035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000017/wk-form4_1706909035.xml","form_type":"4"}},{"id":47657,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Common Stock","published_at":"2024-02-02T21:24:31.000Z","date":"2024-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":566,"price":645.61,"value":365415.26,"ownership":{"direct":true},"balance_after":30816,"source":{"system":"sec-edgar","filing":"0000059478-24-000017","document":"wk-form4_1706909035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000017/wk-form4_1706909035.xml","form_type":"4"}},{"id":47656,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Common Stock","published_at":"2024-02-02T21:24:31.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":true,"shares":1268,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31382,"source":{"system":"sec-edgar","filing":"0000059478-24-000017","document":"wk-form4_1706909035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000017/wk-form4_1706909035.xml","form_type":"4"}},{"id":54957,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Common Stock","published_at":"2023-06-15T20:21:12.000Z","date":"2023-06-15","kind":"sale","planned":true,"acquired":false,"shares":1647,"price":448,"value":737856.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 21, 2023."}],"balance_after":30114,"source":{"system":"sec-edgar","filing":"0000059478-23-000188","document":"wk-form4_1686860461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000188/wk-form4_1686860461.xml","form_type":"4"}},{"id":54956,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Common Stock","published_at":"2023-06-15T20:21:12.000Z","date":"2023-06-14","kind":"sale","planned":true,"acquired":false,"shares":1647,"price":444.29,"value":731745.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 21, 2023."}],"balance_after":31761,"source":{"system":"sec-edgar","filing":"0000059478-23-000188","document":"wk-form4_1686860461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000188/wk-form4_1686860461.xml","form_type":"4"}},{"id":58552,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Common Stock","published_at":"2023-02-21T21:32:32.000Z","date":"2023-02-17","kind":"gift","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33408,"source":{"system":"sec-edgar","filing":"0000059478-23-000077","document":"wf-form4_167701512962950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000077/wf-form4_167701512962950.xml","form_type":"4"}},{"id":59139,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2023-02-14T21:52:58.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":1268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":1268,"derivative":{"exercise_date":"2024-02-01","expiration_date":"2024-02-01","underlying":"Common Stock","underlying_shares":1268},"source":{"system":"sec-edgar","filing":"0000059478-23-000057","document":"wf-form4_167641155807782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000057/wf-form4_167641155807782.xml","form_type":"4"}},{"id":59138,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Common Stock","published_at":"2023-02-14T21:52:58.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":2507,"price":345.12,"value":865215.84,"ownership":{"direct":true},"balance_after":33908,"source":{"system":"sec-edgar","filing":"0000059478-23-000057","document":"wf-form4_167641155807782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000057/wf-form4_167641155807782.xml","form_type":"4"}},{"id":59506,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2023-02-03T21:54:52.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":2102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2023-02-01","expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":2102},"source":{"system":"sec-edgar","filing":"0000059478-23-000037","document":"wf-form4_167546127265548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000037/wf-form4_167546127265548.xml","form_type":"4"}},{"id":59505,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Common Stock","published_at":"2023-02-03T21:54:52.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":941,"price":344.15,"value":323845.15,"ownership":{"direct":true},"balance_after":31401,"source":{"system":"sec-edgar","filing":"0000059478-23-000037","document":"wf-form4_167546127265548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000037/wf-form4_167546127265548.xml","form_type":"4"}},{"id":59504,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Quality"}}],"security":"Common Stock","published_at":"2023-02-03T21:54:52.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":2102,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32342,"source":{"system":"sec-edgar","filing":"0000059478-23-000037","document":"wf-form4_167546127265548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000037/wf-form4_167546127265548.xml","form_type":"4"}},{"id":71148,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2022-02-11T23:22:44.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":2102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":2102,"derivative":{"exercise_date":"2023-02-01","expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":2102},"source":{"system":"sec-edgar","filing":"0000059478-22-000046","document":"wf-form4_164462174983605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000046/wf-form4_164462174983605.xml","form_type":"4"}},{"id":71147,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2022-02-11T23:22:44.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":3294,"price":243.27,"value":801331.38,"ownership":{"direct":true},"balance_after":30240,"source":{"system":"sec-edgar","filing":"0000059478-22-000046","document":"wf-form4_164462174983605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000046/wf-form4_164462174983605.xml","form_type":"4"}},{"id":72141,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2022-02-03T21:59:50.000Z","date":"2022-02-01","kind":"exercise","acquired":false,"shares":2676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2022-02-01","expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":2676},"source":{"system":"sec-edgar","filing":"0000059478-22-000028","document":"wf-form4_164392557628191.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000028/wf-form4_164392557628191.xml","form_type":"4"}},{"id":72140,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2022-02-03T21:59:50.000Z","date":"2022-02-01","kind":"tax_withholding","acquired":false,"shares":1194,"price":245.39,"value":292995.66,"ownership":{"direct":true},"balance_after":26946,"source":{"system":"sec-edgar","filing":"0000059478-22-000028","document":"wf-form4_164392557628191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000028/wf-form4_164392557628191.xml","form_type":"4"}},{"id":72139,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2022-02-03T21:59:50.000Z","date":"2022-02-01","kind":"exercise","acquired":true,"shares":2676,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28140,"source":{"system":"sec-edgar","filing":"0000059478-22-000028","document":"wf-form4_164392557628191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000028/wf-form4_164392557628191.xml","form_type":"4"}},{"id":93853,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2021-02-11T01:36:09.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":2676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":2676,"derivative":{"exercise_date":"2022-02-01","expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":2676},"source":{"system":"sec-edgar","filing":"0000059478-21-000052","document":"wf-form4_161300734811911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947821000052/wf-form4_161300734811911.xml","form_type":"4"}},{"id":93852,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2021-02-11T01:36:09.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":6040,"price":205.77,"value":1242850.8,"ownership":{"direct":true},"balance_after":25464,"source":{"system":"sec-edgar","filing":"0000059478-21-000052","document":"wf-form4_161300734811911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947821000052/wf-form4_161300734811911.xml","form_type":"4"}},{"id":94341,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2021-02-03T23:38:28.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":3435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2021-02-01","expiration_date":"2021-02-01","underlying":"Common Stock","underlying_shares":3435},"source":{"system":"sec-edgar","filing":"0000059478-21-000024","document":"wf-form4_161239548901874.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947821000024/wf-form4_161239548901874.xml","form_type":"4"}},{"id":94340,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2021-02-03T23:38:28.000Z","date":"2021-02-01","kind":"tax_withholding","acquired":false,"shares":1529,"price":207.97,"value":317986.13,"ownership":{"direct":true},"balance_after":19424,"source":{"system":"sec-edgar","filing":"0000059478-21-000024","document":"wf-form4_161239548901874.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947821000024/wf-form4_161239548901874.xml","form_type":"4"}},{"id":94339,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2021-02-03T23:38:28.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":3435,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20953,"source":{"system":"sec-edgar","filing":"0000059478-21-000024","document":"wf-form4_161239548901874.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947821000024/wf-form4_161239548901874.xml","form_type":"4"}},{"id":94489,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2021-02-02T22:16:16.000Z","date":"2020-04-28","kind":"gift","acquired":false,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17518,"source":{"system":"sec-edgar","filing":"0000059478-21-000016","document":"wf-form5_161230415317974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947821000016/wf-form5_161230415317974.xml","form_type":"5"}},{"id":106098,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2020-03-18T14:44:09.000Z","date":"2020-03-16","kind":"sale","acquired":false,"shares":4727,"price":131,"value":619237.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2020."}],"balance_after":17674,"source":{"system":"sec-edgar","filing":"0000059478-20-000074","document":"wf-form4_158454263137522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947820000074/wf-form4_158454263137522.xml","form_type":"4"}},{"id":107779,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2020-02-18T19:57:01.000Z","date":"2020-02-16","kind":"exercise","acquired":false,"shares":97,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by partner"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2020-02-16","expiration_date":"2020-02-16","underlying":"Common Stock","underlying_shares":97},"source":{"system":"sec-edgar","filing":"0000059478-20-000054","document":"wf-form4_158205580329645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947820000054/wf-form4_158205580329645.xml","form_type":"4"}},{"id":107778,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2020-02-18T19:57:01.000Z","date":"2020-02-16","kind":"tax_withholding","acquired":false,"shares":34,"price":141.12,"value":4798.08,"ownership":{"direct":false,"nature":"by partner"},"balance_after":128,"source":{"system":"sec-edgar","filing":"0000059478-20-000054","document":"wf-form4_158205580329645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947820000054/wf-form4_158205580329645.xml","form_type":"4"}},{"id":107777,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2020-02-18T19:57:01.000Z","date":"2020-02-16","kind":"exercise","acquired":true,"shares":97,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by partner"},"balance_after":162,"source":{"system":"sec-edgar","filing":"0000059478-20-000054","document":"wf-form4_158205580329645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947820000054/wf-form4_158205580329645.xml","form_type":"4"}},{"id":107927,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2020-02-13T22:46:19.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":3435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":3435,"derivative":{"exercise_date":"2021-02-01","expiration_date":"2021-02-01","underlying":"Common Stock","underlying_shares":3435},"source":{"system":"sec-edgar","filing":"0000059478-20-000034","document":"wf-form4_158163396149191.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947820000034/wf-form4_158163396149191.xml","form_type":"4"}},{"id":107926,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2020-02-13T22:46:19.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":1778,"price":144.25,"value":256476.5,"ownership":{"direct":true},"balance_after":22401,"source":{"system":"sec-edgar","filing":"0000059478-20-000034","document":"wf-form4_158163396149191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947820000034/wf-form4_158163396149191.xml","form_type":"4"}},{"id":108735,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2020-02-03T21:50:01.000Z","date":"2019-03-07","kind":"gift","acquired":false,"shares":196,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20623,"source":{"system":"sec-edgar","filing":"0000059478-20-000014","document":"wf-form5_158076658467404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947820000014/wf-form5_158076658467404.xml","form_type":"5"}},{"id":119864,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2019-02-20T20:52:03.000Z","date":"2019-02-16","kind":"exercise","acquired":false,"shares":48,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by partner"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest in three installments, 48 on February 16, 2018; 48 on February 16, 2019; and 97 on February 16, 2020."}],"balance_after":97,"derivative":{"expiration_date":"2020-02-16","underlying":"Common Stock","underlying_shares":48},"source":{"system":"sec-edgar","filing":"0000059478-19-000112","document":"wf-form4_155069590817698.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000112/wf-form4_155069590817698.xml","form_type":"4"}},{"id":119863,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2019-02-20T20:52:03.000Z","date":"2019-02-16","kind":"tax_withholding","acquired":false,"shares":17,"price":122.48,"value":2082.16,"ownership":{"direct":false,"nature":"by partner"},"balance_after":65,"source":{"system":"sec-edgar","filing":"0000059478-19-000112","document":"wf-form4_155069590817698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000112/wf-form4_155069590817698.xml","form_type":"4"}},{"id":119862,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2019-02-20T20:52:03.000Z","date":"2019-02-16","kind":"exercise","acquired":true,"shares":48,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by partner"},"balance_after":82,"source":{"system":"sec-edgar","filing":"0000059478-19-000112","document":"wf-form4_155069590817698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000112/wf-form4_155069590817698.xml","form_type":"4"}},{"id":119867,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2019-02-20T20:46:26.000Z","date":"2019-02-04","kind":"grant","acquired":true,"shares":2960,"price":120.17,"value":355703.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed to correctly report the amount acquired in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5."}],"balance_after":20819,"source":{"system":"sec-edgar","filing":"0000059478-19-000109","document":"wf-form4a_155069557190530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000109/wf-form4a_155069557190530.xml","form_type":"4/A","original_submission_date":"2019-02-06"}},{"id":120461,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2019-02-07T00:22:31.000Z","date":"2019-02-04","kind":"grant","acquired":true,"shares":2958,"price":120.17,"value":355462.86,"ownership":{"direct":true},"balance_after":20817,"source":{"system":"sec-edgar","filing":"0000059478-19-000057","document":"wf-form4_154949893755930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000057/wf-form4_154949893755930.xml","form_type":"4"}},{"id":123222,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2018-11-06T18:25:38.000Z","date":"2018-11-03","kind":"exercise","acquired":false,"shares":3133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2018-11-03","expiration_date":"2018-11-03","underlying":"Common Stock","underlying_shares":3133},"source":{"system":"sec-edgar","filing":"0000059478-18-000258","document":"wf-form4_154152872203725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000258/wf-form4_154152872203725.xml","form_type":"4"}},{"id":123221,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2018-11-06T18:25:38.000Z","date":"2018-11-03","kind":"tax_withholding","acquired":false,"shares":1366,"price":106.75,"value":145820.5,"ownership":{"direct":true},"balance_after":17859,"source":{"system":"sec-edgar","filing":"0000059478-18-000258","document":"wf-form4_154152872203725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000258/wf-form4_154152872203725.xml","form_type":"4"}},{"id":123220,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2018-11-06T18:25:38.000Z","date":"2018-11-03","kind":"exercise","acquired":true,"shares":3133,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19225,"source":{"system":"sec-edgar","filing":"0000059478-18-000258","document":"wf-form4_154152872203725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000258/wf-form4_154152872203725.xml","form_type":"4"}},{"id":131922,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Restricted Stock Unit","published_at":"2018-02-21T15:28:29.000Z","date":"2018-02-16","kind":"exercise","acquired":false,"shares":48,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by partner"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest in three installments, 48 on February 16, 2018; 48 on February 16, 2019; and 97 on February 16, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest in three installments, 48 on February 16, 2018; 48 on February 16, 2019; and 97 on February 16, 2020."}],"balance_after":145,"derivative":{"underlying":"Common Stock","underlying_shares":48},"source":{"system":"sec-edgar","filing":"0000059478-18-000091","document":"wf-form4_151922689429729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000091/wf-form4_151922689429729.xml","form_type":"4"}},{"id":131921,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2018-02-21T15:28:29.000Z","date":"2018-02-16","kind":"tax_withholding","acquired":false,"shares":14,"price":78.02,"value":1092.28,"ownership":{"direct":false,"nature":"by partner"},"balance_after":34,"source":{"system":"sec-edgar","filing":"0000059478-18-000091","document":"wf-form4_151922689429729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000091/wf-form4_151922689429729.xml","form_type":"4"}},{"id":131920,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2018-02-21T15:28:29.000Z","date":"2018-02-16","kind":"exercise","acquired":true,"shares":48,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by partner"},"balance_after":48,"source":{"system":"sec-edgar","filing":"0000059478-18-000091","document":"wf-form4_151922689429729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000091/wf-form4_151922689429729.xml","form_type":"4"}},{"id":133225,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11395,"kind":"person","name":"Norton Johna","position":1,"cik":"0001702471","reported_name":"Norton Johna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Global Quality"}}],"security":"Common Stock","published_at":"2018-01-31T23:08:19.000Z","date":"2018-01-29","kind":"grant","acquired":true,"shares":1599,"price":87.6,"value":140072.4,"ownership":{"direct":true},"balance_after":16092,"source":{"system":"sec-edgar","filing":"0000059478-18-000046","document":"wf-form4_151744008557820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000046/wf-form4_151744008557820.xml","form_type":"4"}}]}